{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:53:28Z","timestamp":1761432808052,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.contraception.2011.12.016","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T08:15:56Z","timestamp":1332490556000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone\/EE vs. a second-generation oral contraceptive containing levonorgestrel\/EE"],"prefix":"10.1016","volume":"86","author":[{"given":"Mandana","family":"Rad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobus","family":"Burggraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke L.","family":"de Kam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam F.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Kluft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.12.016_bb0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.12.016_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13625180701300194","article-title":"Combined hormonal contraception and venous thromboembolism","volume":"12","author":"Martinez","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.12.016_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"year":"1981","series-title":"Discrimination and Classification","author":"Hand","key":"10.1016\/j.contraception.2011.12.016_bb0020"},{"key":"10.1016\/j.contraception.2011.12.016_bb0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-0038-1635283","article-title":"Discriminant analysis and its applications in epidemiology","volume":"19","author":"Lachenbruch","year":"1980","journal-title":"Methods Inf Med"},{"year":"1984","series-title":"Multivariate Analysis: Methods and Applications","author":"Dillion","key":"10.1016\/j.contraception.2011.12.016_bb0030"},{"key":"10.1016\/j.contraception.2011.12.016_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijcard.2006.04.051","article-title":"Cigarette smoking and myocardial infarction in young men and women: a case-control study","volume":"116","author":"Panagiotakos","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.contraception.2011.12.016_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1358\/mf.2000.22.2.796074","article-title":"Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment outcome in Alzheimer's disease","volume":"22","author":"Knott","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.contraception.2011.12.016_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0954-6111(97)90063-9","article-title":"Evaluation of response to chemotherapy in patients affected with non-small cell lung cancer by means of three tumour markers elaborated by discriminant analysis","volume":"91","author":"Paone","year":"1997","journal-title":"Respir Med"},{"key":"10.1016\/j.contraception.2011.12.016_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.12.016_bb0055","unstructured":"European Medicines Agency \u2014 Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. 2005; EMEA\/CPMP\/EWP\/519\/98 Rev 1."},{"key":"10.1016\/j.contraception.2011.12.016_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.12.016_bb0065","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.12.016_bb0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2011.12.016_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2003-38334","article-title":"Venous and arterial thrombosis during oral contraceptive use: risks and risk factors","volume":"3","author":"Tanis","year":"2003","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.contraception.2011.12.016_bb0080","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1538-7836.2005.01430.x","article-title":"Determinants of the APTT- and ETP-based APC sensitivity tests","volume":"3","author":"de Visser","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2011.12.016_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2011.12.016_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/00365516809077003","article-title":"Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins","volume":"21","author":"Laurell","year":"1968","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.contraception.2011.12.016_bb0095","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(70)92358-5","article-title":"Effect of combined oestrogen\u2013progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity","volume":"2","author":"Howie","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.12.016_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0037-1613603","article-title":"Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis","volume":"90","author":"Teresa","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2011.12.016_bb0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.maturitas.2009.01.004","article-title":"Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone","volume":"62","author":"Hellgren","year":"2009","journal-title":"Maturitas"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:38Z","timestamp":1761432278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411007487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0010782411007487"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.12.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone\/EE vs. a second-generation oral contraceptive containing levonorgestrel\/EE","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2011.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}